首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >Lipid peroxidation and spectrin of RBC membrane in hydroxyurea treated Eβ thalassaemia
【2h】

Lipid peroxidation and spectrin of RBC membrane in hydroxyurea treated Eβ thalassaemia

机译:羟基脲治疗的Eβ地中海贫血中RBC膜的脂质过氧化和光谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present work is to understand the effect of low dose of hydroxyurea (HU) therapy on oxidative damage of RBC membrane in non-transfused Eβ thalassaemia. HU was administered at a dose of 30 mg/kg/day for 90 consecutive days. The percentage of spectrin and the level of malondialdehyde (MDA), fetal hemoglobin (HbF), hemoglobin (Hb) and packed cell volume (PCV) were measured. The HbF level was significantly increased after 90 days of HU therapy. MDA level of RBC membrane was decreased. There was no change in PCV, Hb and spectrin content of RBC membrane after HU therapy for 90 days in Eβ thalassaemia. Increment of HbF in HU treated Eβ patient may have some role on the correction of oxidative damage of RBC membrane by inhibiting further degradation of spectrin and by decreasing lipid peroxidation of red cell membrane.
机译:本工作的目的是了解低剂量的羟基脲(HU)治疗对非输血性Eβ地中海贫血中RBC膜的氧化损伤的影响。连续90天以30 mg / kg /天的剂量给予HU。测量血影蛋白的百分比和丙二醛(MDA),胎儿血红蛋白(HbF),血红蛋白(Hb)和堆积细胞体积(PCV)的水平。 HU治疗90天后HbF水平显着升高。 RBC膜的MDA水平降低。 Eβ地中海贫血经过90天的HU治疗后,RBC膜的PCV,Hb和血影蛋白含量没有变化。 HU治疗的Eβ患者中HbF的增加可能通过抑制血红蛋白的进一步降解和减少红细胞膜的脂质过氧化作用而对RBC膜的氧化损伤的纠正有一定作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号